Citigroup’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.1K | Sell |
|
|||||
|
2025
Q2 | $103K | Sell |
|
|||||
|
2025
Q1 | $144K | Sell |
|
|||||
|
2024
Q4 | $311K | Buy |
|
|||||
|
2024
Q3 | $160K | Buy |
|
|||||
|
2024
Q2 | $35.7K | Buy |
|
|||||
|
2024
Q1 | $41.6K | Buy |
|
|||||
|
2023
Q4 | $24.8K | Buy |
|
|||||
|
2023
Q3 | $3.39K | Sell |
|
|||||
|
2023
Q2 | $75.2K | Buy |
|
|||||
|
2023
Q1 | $8.09K | Sell |
|
|||||
|
2022
Q4 | $10.2K | Sell |
|
|||||
|
2022
Q3 | $12K | Sell |
|
|||||
|
2022
Q2 | $31K | Buy |
|
|||||
|
2022
Q1 | $35K | Sell |
|
|||||
|
2021
Q4 | $98K | Buy |
|
|||||
|
2021
Q3 | $29K | Buy |
|